SEARCH RESULTS FOR:
Serialization Regulations Put Packaging Into the Limelight
United States Biopharmaceuticals 2019
Changing serialization requirements represent an opportunity for packaging companies that are looking to add value for their clients.
Alan Rubino
CEO, EMISPHERE TECHNOLOGIES
United States Biopharmaceuticals 2019
Emisphere Technologies is a leading company in converting injectable therapeutics into advanced oral formulations.
Stephen Wang & Ryan Yoder
CHAIRMAN and CEO & VP BUSINESS DEVELOPMENT, KINGCHEM LIFE SCIENCE
United States Biopharmaceuticals 2019
Kingchem provides contract development and manufacturing services to the pharmaceutical and chemical industries.
Karen Fallen
SENIOR VICE PRESIDENT: BUSINESS UNIT HEAD - CLINICAL DEVELOPMENT & MANUFACTURING, LONZA
United States Biopharmaceuticals 2019
Lonza is one of the world's leading suppliers to the pharma, biotech and specialty ingredient markets.
Shabbir Dahod
PRESIDENT AND CEO, TRACELINK
United States Biopharmaceuticals 2019
TraceLink is the world’s largest integrated digital supply network connecting the life sciences supply chain.
Peter Hall
CEO, AUSTRALIAN DRILLING INDUSTRY ASSOCIATION (ADIA)
The Australian Drilling Industry Association (ADIA) is a not-for-profit organization representing the drilling industry nationally.
Christiana Goh Bardon
MD, MBA, MANAGING DIRECTOR, UBS ONCOLOGY IMPACT FUND MANAGED BY MPM CAPITAL & PORTFOLIO MANAGER, BURRAGE CAPITAL FUND
UBS Oncology Impact Fund is an evergreen fund specializing in investments in early stage oncology and cancer therapeutics.
Ted Moses O.Q
President, SAENCAT
The Secretariat promotes sustainable relations and socio-economic alliances across the region to foster harmonious development.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Latam North and Caribbean Mining 2025 - Digital Interactive
A convergence of high-commodity prices and low valuations, on the back of a structural deficit in exploration and discoveries, has set the perfect scene for increased M&A. The leverage is particularly high for acquisitions in Latam North and the Caribbean, where stocks do not command the high premiums of tier-one jurisdictions. But M&A is only a quick fix to the global resource replenishment crisis.
A convergence of high-commodity prices and low valuations, on the back of a structural deficit in exploration and discoveries, has set the perfect scene for increased M&A. The leverage is particularly high for acquisitions in Latam North and the Caribbean, where stocks do not command the high premiums of tier-one jurisdictions. But M&A is only a quick fix to the global resource replenishment crisis.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
